Updated Jul 16, 2026
Mertens Steve is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.

Steve Mertens is the Chief Technology Officer at NeuroOne Medical Technologies Corp, a company specializing in technologies for brain-related conditions. He has been involved in multiple SEC filings related to his role but has not reported any stock transactions.
| Role | Chief Technology Officer |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-01 | NMTC | NEUROONE MEDICAL TECHNOLOGIES Corp | F — Tax withholding / forfeiture | 906 | $0.78 | $704 |
| 2026-02-20 | NMTC | NEUROONE MEDICAL TECHNOLOGIES Corp | F — Tax withholding / forfeiture | 7.4K | $0.68 | $5K |
| 2025-09-30 | NMTC | NEUROONE MEDICAL TECHNOLOGIES Corp | F — Tax withholding / forfeiture | 906 | $0.89 | $805 |
| 2025-06-30 | NMTC | NEUROONE MEDICAL TECHNOLOGIES Corp | F — Tax withholding / forfeiture | 906 | $0.68 | $614 |
| 2024-12-03 | NMTC | NEUROONE MEDICAL TECHNOLOGIES Corp | F — Tax withholding / forfeiture | 252 | $0.62 | $157 |
| 2024-11-01 | NMTC | NEUROONE MEDICAL TECHNOLOGIES Corp | F — Tax withholding / forfeiture | 252 | $0.97 | $244 |
| 2024-10-02 | NMTC | NEUROONE MEDICAL TECHNOLOGIES Corp | F — Tax withholding / forfeiture | 1.2K | $0.99 | $1K |
Steve Mertens is the Chief Technology Officer at NeuroOne Medical Technologies Corp, a company specializing in technologies for brain-related conditions. He has been involved in multiple SEC filings related to his role but has not reported any stock transactions.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Mertens Steve profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.